I can’t give an exact dollar figure for a manufacturing plant to produce ethacrynic acid, but I can help you think about the costs and what drives them. The total cost depends heavily on capacity, location, and regulatory requirements.
Key cost drivers
- Capacity and scale: daily/annual throughput (kg/day or kg/year) and whether the line is dedicated to ethacrynic acid or multi-product.
- Process complexity: number of synthetic steps, need for advanced purification, crystallization, solvent recovery, and waste treatment.
- GMP/compliance: cleanrooms, HVAC, containment, qualification and validation (DQ/UQ/PQ), QA/QC labs, analytical instrumentation, documentation systems.
- Utilities and site infrastructure: water purification, steam, electricity, compressed air, waste treatment, solvent recovery systems.
- Equipment and construction: reactors, crystallizers, filtration/IA filtration, dryers, dryers, fill/finish or packaging lines (if integrated), piping, containment, utilities ramps.
- Quality control and analytical: in-process and finished-product testing, stability studies, reference standards, data systems.
- Regulatory and commissioning: permits, inspections, validation campaigns, potential audits.
- Improvement/transition risk: potential need for scale-up, process optimization, and technology transfer.
- Location factors: labor costs, local regulations, import duties, currency risk, and availability of qualified EPC/CMO partners.
Rough, ballpark ranges (order of magnitude only)
- Feasibility/pilot facility (small scale, tens to a few hundred kg/year): commonly in the low millions of USD, but can be higher if cleanroom and regulatory readiness are required.
- Small-to-mid commercial facility (a few hundred kg/day to a few tons/year): typically tens of millions of USD to the low hundreds of millions.
- Large-scale commercial facility (tens of tons/year): often hundreds of millions of USD, depending on capacity, architecture (single-use vs stainless steel, multi-use), and utility demands.
Notes:
- These are very rough ranges to illustrate scale. Exact numbers depend on capacity, site, vendor choices, and the level of GMP sophistication.
- A Lang-factor style rough estimate (equipment cost multiplied by a factor to cover installation, utilities, and commissioning) is sometimes used in early budgeting, but it varies by project complexity in pharma.
How to get a more concrete figure
- Define target capacity and product scope: e.g., kg/day throughput, number of shifts, ancillaries, packaging scope.
- Decide greenfield vs. expansion: brand-new site often costs more upfront but can be optimized for GMP from the ground up.
- Get ROMs from vendors: approach API contract manufacturers (CMOs) and API/EPC suppliers with a brief process description and capacity target to obtain rough quotes.
- Consult an experienced pharma EPC (engineering-procurement-construction) firm for a feasibility study and a high-level CAPEX estimate.
- Consider regulatory/compliance costs as a separate line item (filings, inspections, validation, quality systems).
If you share:
- Target annual API volume (kg/year)
- Desired scale (e.g., kg/day or ton/year)
- Whether it’s a new facility or an expansion
- Preferred region/location
- Any specific regulatory needs (FDA/EMA, etc.)
I can help you put together a more focused, rough cost framework and a checklist to use with vendors. I can also draft a simple RFQ/template you could send to CMOs and EPCs to capture ROMs.